PD17-13: Residual Stone Volume Outperforms Stone-Free Status in Predicting Healthcare Utilization After Ureteroscopy: Secondary Analysis of the ASPIRE Trial

PD17-13: Residual Stone Volume Outperforms Stone-Free Status in Predicting Healthcare Utilization After Ureteroscopy: Secondary Analysis of the ASPIRE Trial

Sunday, May 17, 2026 8:36 AM to 8:44 AM · 8 min. (America/New_York)
206
Abstract

Log in

See all the content and easy-to-use features by logging in or registering!